The Asymmetry of Expectations on the Outcomes of Strategic Alliances Between Biotechnology Start-Ups and Pharmaceutical Corporations

Abstract

This chapter focuses on the relationship between biotechnology start-ups and larger pharmaceutical corporations when they work as partners in innovation strategic alliances. For three decades, these companies have become major players in innovation in the health sector. This means that the development of many products is a result of the cooperation they carry out. However, due to the great differences between these companies, certain problems can often arise. More specifically, our analysis explores the perceptions of the achievement expected by each partner. This is an important aspect to determine the satisfaction of these firms among strategic alliance. The authors follow qualitative methods to address the topic, conducting personal interviews with managers of these companies. Our findings reveal the concrete facts that can prevent reaching the proposed goals of these partners as well as stress the crucial importance of the human aspect to mitigate potential problems.

Citation

Márquez, F.B., Pérez, S.D. and Udina, E.S. (2023), "The Asymmetry of Expectations on the Outcomes of Strategic Alliances Between Biotechnology Start-Ups and Pharmaceutical Corporations", Fernández Pérez, P. and San Román, E. (Ed.) Collective Entrepreneurship in the Contemporary European Services Industries: A Long Term Approach (Frontiers of Management History), Emerald Publishing Limited, Leeds, pp. 117-133. https://doi.org/10.1108/978-1-80117-950-820231008